We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Company Streamlines Detecting, Diagnosing, and Tracking Infectious Disease

By LabMedica International staff writers
Posted on 01 Apr 2014
A company is using its DNA analysis technology in major global collaborations aimed at curbing the spread of viruses such as H1N1 or avian flu, in real time.

The Jerusalem-based subsidiary of Azure PCR (Jerusalem, Israel) has streamlined the process of detecting, diagnosing, and tracking infectious diseases. More...
The company is participating in the largest-ever child health study, the Johns Hopkins (Baltimore, MD, USA)-based PERCH (Pneumonia Etiology Research for Child Health. This multicountry study of hospitalized pediatric patients with severe pneumonia aims to advance new lab techniques in order to better determine causes and risk factors, as well as guide the development of new vaccines and treatments.

The Israeli company’s role in this USD 260 million study is its unique capability for fast and automated data analysis. At this early stage, however, the company is not focusing on consumer application but on using its automatic DNA analysis technology in major global collaborations aimed at curbing the spread of viruses such as H1N1 or avian flu, in real time.

There are three steps to the process: extracting the DNA from a urine or blood sample, testing the DNA, and analyzing the results. The first two steps were automated before Azure PCR came on the scene. Real-time polymerase chain reaction (PCR) is the most popular molecular diagnostic technique in use today, accounting for more than USD 2.8 billion in sales. The breakthrough is automating the analysis step—greatly speeding up the process, removing the need for specially trained technicians (a particularly acute issue for developing countries where skilled professionals can be hard to find), and eliminating room for error in interpreting results.

CEO of Azure PCR, Aron Cohen said, “We make the subjective objective. We can provide standardized results without the need for skilled personnel. With major global pandemics such as SARS and swine flu, we saw a 6- to 18-month lag in diseases that start[ed] in developing nations until spreading to the West, so being able to track these in real time can make prevention through vaccination and other methods possible,” Cohen explained.

“Putting early warning systems in place can improve people’s lives and cut down on the cost of universal healthcare. If we know there is a disease spreading from a town and can map its distribution patterns, targeted vaccination can prevent it from spreading. Prevention is always better than cure.”

Related Links:

Azurepcr
Johns Hopkins 



New
Gold Member
Automated MALDI-TOF MS System
EXS 3000
Collection and Transport System
PurSafe Plus®
New
Gold Member
Automated Blood Culture System
EXB 120
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.